*SEGNALAZIONE AI COMANDI DELLA GUARDIA DI FINANZA:* *LA PIU' GRANDE FRODE ALLO STATO ITALIANO MAI COMMESSA* *Midazolam* somministrato in concomitanza con antibiotico via endovena e' provato da *PubMed n. ID 11575933* che provochi depressione polmonare profonda che giustifica il ricovero in Terapia Intensiva che permette alle Aziende Ospedaliere Spa di incassare dalla Regione il DRG n.541 di 51.919,00 euro. *Frode allo Stato.* _Quante e quali sono le Aziende Ospedaliere Spa coinvolte?_ _Quali sono i primari Anestesisti e i primari Cardiologi coinvolti?_ _Quali sono i partiti politici che hanno ricevuto donazioni da primari le cui Aziende Ospedaliere hanno ricevuto il contributo DRG n. 541 dalla Regione_ ? *Una frode allo Stato colossale, miliardaria, che riguarda almeno 500.000 ricoveri in Terapia Intensiva avvenuti dal 2012 ad oggi* , da quando fu modificato il rimborso dalla Regione per il ricovero in Terapia intensiva, portandolo da 300,00 euro al giorno a 51.919,00 euro se il ricovero in Terapia Intensiva si e' protratto per almeno 4 giorni, un incremento di rimborso di circa 50 volte a partite dal 2012, a 34.546,00 euro anche se eseguito solo con maschera a membrana Venturi (DRG n.542). La Magistratura attuale avrà le forza di smantellare la più grande truffa allo Stato mai commessa o i politici si interporranno spostando Pubblici Ministeri, GIP e Procuratori Capo dai luoghi di indagine, impedendo l' inizio dell' indagine, impedendo quindi alle Forze dell' Ordine di iniziare a compiere indagini di Polizia Giudiziaria? La presente costituisce Segnalazione, e non esposto, ai Comandi della Guardia di Finanza. Ai sensi dell' art 347 e seguenti del Codice di Procedura Penale, la Segnalazione consente alla Polizia Giudiziaria di compiere atti di indagine prima che il Pubblico Ministero assuma formalmente la direzioni delle indagini. *Il Midazolam prolunga il suo potente effetto sedativo provocando depressione polmonare profonda che giustifica il ricovero in Terapia intensiva anche in caso di occlusione delle vie urinarie (provato da PubMed n. ID 1767626 ),* per esempio per pezzi di carne nel canale urinario da strappo traumatico del catetere vescicale, per intervenuta impossibilità di espellerlo con le urine, quanti cateteri vescicali sono stati strappati in queste *Aziende Ospedaliere Spa* che poi hanno incassato il contributo DRG .n. 541 e n. 542 dalla Regione? _Quanti pazienti sono deceduti dopo 8 giorni dal ricovero, provocando, Midazolam più antibiotico via endovena, anche sedazione dell'epiglottide impedendo di bere e di mangiare?_ *Omicidio doloso.* Anche quest'ultima notizia di reato costituisce Segnalazione ai Comandi della Guardia di Finanza. @AlessandroGovoni Source: ➡ t.me/SaDefenza

Seven Chakra Crystal Tree - Peace and Positivity https://bejandaruwalla.com/collections/others/products/seven-chakra-crystal-tree A Seven Chakra Crystal Tree is a beautiful and powerful decorative piece designed to harmonize the seven energy centers, or chakras, of the body. This tree typically consists of seven distinct types of crystals, each corresponding to one of the chakras: Amethyst (Crown Chakra), Lapis Lazuli (Third Eye Chakra), Turquoise (Throat Chakra), Green Aventurine (Heart Chakra), Citrine (Solar Plexus Chakra), Carnelian (Sacral Chakra), and Red Jasper (Root Chakra).

Green Aventurine Pyramid - provides health and emotional peace https://bejandaruwalla.com/collections/others/products/green-aventurine-pyramid A Green Aventurine Pyramid is a striking and powerful crystal formation that combines both aesthetic beauty and healing properties. Known as the “Stone of Luck,” Green Aventurine is famous for its ability to attract abundance, prosperity, and new opportunities. The pyramid shape itself is highly symbolic in many cultures, representing stability, balance, and spiritual growth.

Green Aventurine Ball https://bejandaruwalla.com/collections/others/products/green-aventurine-ball A Green Aventurine Ball is a beautiful and energizing crystal that captivates with its smooth, polished surface and vibrant green color. Known as the "Stone of Opportunity," green aventurine is highly regarded for attracting luck, prosperity, and success. It is often associated with the heart chakra, making it an ideal stone for promoting emotional healing, balancing energies, and fostering love and compassion.

The global urinary incontinence devices market is experiencing significant growth, driven by an aging population, increasing prevalence of chronic conditions, and advancements in medical technology. The global Urinary Incontinence Device Market size is expected to reach USD 6,607.02 Million by 2032, according to a new study by Polaris Market Research. Market Overview: Urinary incontinence, characterized by the involuntary leakage of urine, affects millions globally, particularly among the elderly and those with underlying health conditions. The market encompasses a range of devices designed to manage this condition, including urethral slings, vaginal slings, external continence devices, penile clamps, and electrical stimulation devices. These products aim to improve the quality of life for individuals suffering from urinary incontinence by providing effective and discreet solutions.​ Key Market Growth Drivers: Aging Population: The global increase in life expectancy has led to a higher proportion of elderly individuals, a demographic more susceptible to urinary incontinence. This trend is particularly evident in regions like North America and Europe, where the aging population is substantial. Rising Prevalence of Chronic Conditions: Conditions such as diabetes, obesity, and neurological disorders contribute to the onset of urinary incontinence. The growing incidence of these chronic diseases is directly influencing the demand for incontinence management devices . Advancements in Medical Technology: Innovations in medical technology have led to the development of more comfortable, effective, and minimally invasive urinary incontinence devices. These advancements enhance patient compliance and satisfaction, thereby driving market growth. Increasing Awareness and Acceptance: There is a growing awareness about urinary incontinence and its management options. This has reduced the stigma associated with the condition, encouraging more individuals to seek treatment and utilize incontinence devices. Market Challenges: High Cost of Devices: The expense associated with advanced urinary incontinence devices can be prohibitive for some patients, especially in developing regions. This financial barrier limits access to necessary treatment for a significant portion of the population. Regulatory Hurdles: Stringent regulatory requirements and lengthy approval processes can delay the availability of new devices in the market. Manufacturers must navigate complex regulatory landscapes to ensure timely product launches. Social Stigma: Despite increased awareness, urinary incontinence remains a sensitive topic. The stigma associated with the condition can deter individuals from seeking help and utilizing available devices, impacting market growth. Potential Complications: Some urinary incontinence devices may lead to adverse effects or complications, such as urinary tract infections. These risks can affect patient confidence and willingness to adopt certain products . https://www.polarismarketresearch.com/industry-analysis/urinary-incontinence-device-market Regional Analysis: North America: North America holds a dominant share in the urinary incontinence devices market, attributed to a large aging population, high healthcare expenditure, and advanced medical infrastructure. The United States, in particular, is a significant contributor to this market segment .​ Europe: Europe also represents a substantial portion of the market, with countries like Germany, France, and the UK witnessing increased adoption of incontinence devices. The region's well-established healthcare systems and growing elderly population are key factors driving market growth.​Asia-Pacific: The Asia-Pacific region is anticipated to exhibit the highest CAGR during the forecast period. Countries such as China and India are experiencing rapid urbanization, improving healthcare infrastructure, and rising disposable incomes, leading to increased demand for urinary incontinence devices .​ Latin America and Middle East & Africa: Emerging markets in these regions present significant growth opportunities due to improving healthcare access and increasing awareness about urinary incontinence management. However, challenges like economic instability and limited healthcare resources may impact market expansion.​ Key Companies in the Market: Boston Scientific Corporation: A leading player in the medical device industry, Boston Scientific offers a range of urinary incontinence products, including male slings and artificial urinary sphincters. Johnson & Johnson: Through its Ethicon division, Johnson & Johnson provides surgical solutions for urinary incontinence, focusing on minimally invasive procedures. Coloplast A/S: Coloplast specializes in developing innovative continence care products, such as external catheters and drainage bags, catering to both men and women. Medtronic Plc: Medtronic offers a comprehensive portfolio of urinary incontinence devices, including neuromodulation therapy products and surgical implants. Teleflex Incorporated: Teleflex provides a variety of urological products, including catheters and drainage systems, designed to manage urinary incontinence effectively. Conclusion: The urinary incontinence devices market is on a robust growth trajectory, driven by demographic shifts, technological advancements, and increased awareness. While challenges such as high costs and social stigma persist, the expanding global market presents significant opportunities for innovation and expansion. Stakeholders, including manufacturers, healthcare providers, and policymakers, must collaborate to enhance access to effective urinary incontinence management solutions, ultimately improving the quality of life for individuals affected by this condition. More Trending Latest Reports By Polaris Market Research: Wood Coatings Market Co2 Dosing System Market Supplier Management Market Automotive Aftermarket Market Digital Textile Printing Market Eye Tracking Market Drainage Bottles Market Cloud Billing Market Convergent billing Market

AL BANDO IL FLUORO ROBERT KENNEDY JR COLPISCE ANCORA 💪 @RobertKennedyJr: "Le prove contro il fluoro sono ormai schiaccianti". "Sappiamo che causa una profonda perdita del quoziente intellettivo... e altre lesioni neurologiche come l'ADHD". "Influisce sulla salute dei reni e del fegato, provoca ipotiroidismo e osteoartrite". Ecc... ⬇️⬇️⬇️ https://www.foxnews.com/health/rfk-jr-plans-direct-cdc-stop-recommending-fluoride-water Oramai sono anni che sappiamo che il fluoro fa male alla salute, perché tossico. Ci sono migliaia di studi scientifici, eppure continuano a fare finta di nulla... Forse conviene a qualcuno ignorare di proposito queste informazioni (🤑🤑🤑): "Per fortuna questa pratica aberrante sta per essere bloccata dal nuovo segretario alla salute 𝗥𝗼𝗯𝗲𝗿𝘁 𝗙. 𝗞𝗲𝗻𝗻𝗲𝗱𝘆 𝗝𝗿. Il governatore repubblicano 𝗦𝗽𝗲𝗻𝗰𝗲𝗿 𝗖𝗼𝘅 ha firmato qualche giorno fa una legge che vieta il fluoro nell’acqua pubblica in tutto lo Stato, diventando il primo a farlo. “𝘕𝘰𝘯 𝘢𝘣𝘣𝘪𝘢𝘮𝘰 𝘣𝘪𝘴𝘰𝘨𝘯𝘰 𝘥𝘪 𝘧𝘭𝘶𝘰𝘳𝘰 𝘯𝘦𝘭𝘭𝘢 𝘯𝘰𝘴𝘵𝘳𝘢 𝘢𝘤𝘲𝘶𝘢”, aveva affermato RFK dopo le elezioni. Kennedy su X ha scritto: “𝘪𝘭 𝘧𝘭𝘶𝘰𝘳𝘰 𝘦̀ 𝘶𝘯𝘰 𝘴𝘤𝘢𝘳𝘵𝘰 𝘪𝘯𝘥𝘶𝘴𝘵𝘳𝘪𝘢𝘭𝘦 𝘢𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘰 𝘢𝘥 𝘢𝘳𝘵𝘳𝘪𝘵𝘦, 𝘧𝘳𝘢𝘵𝘵𝘶𝘳𝘦 𝘰𝘴𝘴𝘦𝘦, 𝘥𝘪𝘮𝘪𝘯𝘶𝘻𝘪𝘰𝘯𝘦 𝘥𝘦𝘭 𝘘𝘐, 𝘥𝘪𝘴𝘵𝘶𝘳𝘣𝘪 𝘥𝘦𝘭𝘭𝘰 𝘴𝘷𝘪𝘭𝘶𝘱𝘱𝘰 𝘯𝘦𝘶𝘳𝘰𝘭𝘰𝘨𝘪𝘤𝘰 𝘦 𝘮𝘢𝘭𝘢𝘵𝘵𝘪𝘦 𝘥𝘦𝘭𝘭𝘢 𝘵𝘪𝘳𝘰𝘪𝘥𝘦”. Gli studi non mancano. Nel 2016 di Harvard Public Health ha messo in dubbio la sicurezza dell’acqua fluorurata sollevando le possibilità di tossicità cerebrale, deficit di apprendimento, memoria e cognitivi. Un altro studio ha evidenziato l’associazione tra una maggiore concentrazione di fluoro nelle urine materne in gravidanza e tassi più elevati di problemi neurocomportamentali nei bambini. Infine c'è la ricerca pubblicata su JAMA Pediatrics che non lascia spazio a dubbi: esiste un'associazione statisticamente significativa tra una maggiore esposizione al fluoruro e punteggi inferiori del QI. Oltre all'acqua del sindaco c'è un’altra fonte di fluoro: il dentifricio! E mentre i dentisti continuano a sostenere l'idiozia che il fluoruro nelle paste dentifricie sia fondamentale per la salute dei denti, sempre più persone stanno prendendo coscienza e optano per dentifrici sani totalmente privi di fluoro!" - Marcello Pamio

Drug Screening Market: Competitive Insights and Precise Outlook | 2024-2031 Drug Screening Market Overview: A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Drug Screening market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Drug Screening Industry. Numerous market estimates are provided in the analysis, including those for market size, output, revenue, consumption, CAGR, gross margin, price, and other critical factors. The best primary and secondary research methods and tools on the Drug Screening market were used to build it. Numerous research studies are included in it, including ones on pricing analysis, production and consumption analysis, company profile, and manufacturing cost analysis. Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031). The competitive environment is a crucial element that every key factor needs to be aware of. The study explains the market's competitive landscape so that readers may gauge the degree of both domestic and global rivalry. Additionally, market researchers have provided summaries of each significant firm in the global Drug Screening industry, taking into consideration crucial elements including operational areas, production, and product portfolio. When analyzing the organizations in the study, significant factors including business size, market share, market growth, revenue, production volume, and profitability are also taken into account. The study report uses both qualitative and quantitative data to offer a thorough view of the market. It examines and forecasts the global market in a number of critical industries. The research provides a thorough overview of the industry by segmenting the Drug Screening market into groups based on application, end-user, and location. A thorough research of each market segment was conducted, taking into consideration current and upcoming market trends. Chance to get a free sample @ https://www.skyquestt.com/sample-request/drug-screening-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Drug Screening Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. • Product & Service o Drug Screening Services [Laboratory Testing Services, On-site Testing Services], Drug Screening Products [Analytical Instruments (By Type {Breathalyzers “Fuel-cell Breathalyzers, Semiconductor Breathalyzers, Other Breathalyzers”, Immunoassay analyzers, Chromatography instruments}, By Modality {Hand-held drug screening products, Benchtop drug screening products}, Rapid Testing Devices (Urine testing devices {Drug testing cups, Dip cards, Drug testing cassettes}, Oral fluid testing devices), Consumables {Assay kit, Sample collection devices, Calibrators and controls, Other consumables}] • Sample Type o Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples • Drug Type o Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, Other Drugs • End User o Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Other End Users Get your Customized report @ https://www.skyquestt.com/speak-with-analyst/drug-screening-market Following are the players analyzed in the report: • Quest Diagnostics (US) • Abbott (US) • OraSure Technologies Inc. (US) • Alfa Scientific Designs Inc. (US) • Thermo Fisher Scientific, Inc. (US) • Drägerwerk AG & Co. KGaA (Germany) • Lifeloc Technologies, Inc. (US) • MPD Inc. (US) • Omega Laboratories, Inc. (US) • Premier Biotech, Inc. (US) • Psychemedics Corporation (US) • F. Hoffmann-La Roche Ltd. (Switzerland) • Shimadzu Corporation (Japan) • Siemens Healthineers AG (Germany) • American Bio Medica Corporation (US) • ACM Global Laboratories (US) • CareHealth America Corp. (US) • Clinical Reference Laboratory, Inc. (US) • Intoximeters (US) • Sciteck, Inc. (US) • AccuSourceHR, Inc. (US) • Cordant Health Solutions (US) • Intoxalock (US) • Millennium Health (US) • AdvaCare Pharma (US) Motives for purchasing this report- - A full understanding of customer experiences, upcoming trends, and growth drivers may be obtained by market category analysis. -Drug Screening Market participants will be able to quickly decide on their course of action in order to achieve a competitive advantage thanks to the essential information provided in this area. The factors affecting the sales prospect are carefully examined by SkyQuest Technology Group across several important categories. - Analysing market categories can provide detailed insights into consumer experiences, upcoming trends, and growth-promoting factors. A thorough analysis of market manufacturing trends is a crucial component of the study. -These observations offer crucial information on the ways in which market participants are reacting to the most recent developments that are oversaturating the market. -An in-depth analysis of the numerous organic Buy your full Market Report now: https://www.skyquestt.com/buy-now/drug-screening-market FAQs: 1. What are the main vendors' points of strength and weakness? 2. What are the primary business plans of the leading important players for the near future? 3. What will the market size and growth rate be for Drug Screening in the upcoming year? 4. Which prevailing global trends are affecting the Drug Screening market shares of the leading regions? What effect does Covid19 have on the Industry right now?